Los Angeles Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-69,368
| Closed | -$8.03M | – | 1277 |
|
2023
Q3 | $8.03M | Sell |
69,368
-13,928
| -17% | -$1.61M | 0.03% | 263 |
|
2023
Q2 | $8.57M | Sell |
83,296
-66,023
| -44% | -$6.79M | 0.03% | 276 |
|
2023
Q1 | $16.3M | Buy |
149,319
+3,507
| +2% | +$383K | 0.07% | 223 |
|
2022
Q4 | $16.6M | Sell |
145,812
-9,304
| -6% | -$1.06M | 0.08% | 205 |
|
2022
Q3 | $9.6M | Buy |
+155,116
| New | +$9.6M | 0.05% | 279 |
|
2021
Q4 | – | Sell |
-1,929
| Closed | -$211K | – | 1556 |
|
2021
Q3 | $211K | Buy |
+1,929
| New | +$211K | ﹤0.01% | 1415 |
|
2021
Q2 | – | Sell |
-5,466
| Closed | -$503K | – | 1750 |
|
2021
Q1 | $503K | Sell |
5,466
-76,604
| -93% | -$7.05M | ﹤0.01% | 1216 |
|
2020
Q4 | $6M | Buy |
82,070
+13,319
| +19% | +$974K | 0.03% | 368 |
|
2020
Q3 | $5.34M | Buy |
68,751
+17,569
| +34% | +$1.36M | 0.02% | 352 |
|
2020
Q2 | $2.85M | Buy |
51,182
+32,454
| +173% | +$1.8M | 0.01% | 521 |
|
2020
Q1 | $555K | Buy |
18,728
+5,205
| +38% | +$154K | ﹤0.01% | 877 |
|
2019
Q4 | $490K | Sell |
13,523
-20,435
| -60% | -$740K | ﹤0.01% | 1021 |
|
2019
Q3 | $925K | Sell |
33,958
-30,067
| -47% | -$819K | 0.01% | 824 |
|
2019
Q2 | $1.54M | Sell |
64,025
-2,400
| -4% | -$57.7K | 0.01% | 711 |
|
2019
Q1 | $1.76M | Buy |
+66,425
| New | +$1.76M | 0.01% | 690 |
|
2018
Q4 | – | Sell |
-28,335
| Closed | -$555K | – | 1459 |
|
2018
Q3 | $555K | Buy |
+28,335
| New | +$555K | ﹤0.01% | 1074 |
|
2018
Q2 | – | Sell |
-17,580
| Closed | -$250K | – | 1525 |
|
2018
Q1 | $250K | Buy |
+17,580
| New | +$250K | ﹤0.01% | 1214 |
|
2017
Q4 | – | Sell |
-101,395
| Closed | -$1.29M | – | 1443 |
|
2017
Q3 | $1.29M | Buy |
101,395
+57,360
| +130% | +$728K | 0.01% | 739 |
|
2017
Q2 | $523K | Buy |
+44,035
| New | +$523K | ﹤0.01% | 928 |
|